Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Darryl Toth"'
Autor:
Andrew Blauvelt, Richard G. Langley, Jean-Philippe Lacour, Darryl Toth, Vivian Laquer, Stefan Beissert, Andreas Wollenberg, Pedro Herranz, Andrew E. Pink, Ketty Peris, Stine Fangel, Le Gjerum, Joshua Corriveau, Hidehisa Saeki, Richard B. Warren, Eric Simpson, Kristian Reich
Publikováno v:
Journal of the American Academy of Dermatology. 87:815-824
Additional long-term treatments are needed for moderate-to-severe atopic dermatitis (AD). An ongoing, open-label, 5-year extension trial, ECZTEND (NCT03587805), assesses tralokinumab plus optional topical corticosteroids in participants from previous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5777b6971715865b10b21baa91ca290d
https://doi.org/10.1016/j.jaad.2022.07.019
https://doi.org/10.1016/j.jaad.2022.07.019
Autor:
DirkJan Hijnen, Christina Olsen, Boni E. Elewski, Bo Bang, Darryl Toth, Andrew F Alexis, Jonathan I. Silverberg, T.N. Jensen, Azra Kurbasic, Stephan Weidinger, Andrew Pink, T. Bieber
Publikováno v:
British Journal of Dermatology, 184(3), 450-463. Wiley-Blackwell Publishing Ltd
Background Tralokinumab is a fully human monoclonal antibody that specifically neutralizes interleukin-13, a key driver of atopic dermatitis (AD).Objectives To evaluate the efficacy and safety of tralokinumab in combination with topical corticosteroi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a533d9187308cf44267914fcbc30b2f
https://doi.org/10.1111/bjd.19573
https://doi.org/10.1111/bjd.19573
Autor:
Kim Papp, Jacek C. Szepietowski, Leon Kircik, Darryl Toth, Lawrence F. Eichenfield, Seth B. Forman, Michael E. Kuligowski, Howard Kallender, Kang Sun, Haobo Ren, Eric L. Simpson
Publikováno v:
Journal of the American Academy of Dermatology.
Ruxolitinib cream demonstrated safety and efficacy over 8 weeks in two double-blind phase 3 atopic dermatitis studies (NCT03745638/NCT03745651).Evaluate long-term safety (LTS) and disease control with ruxolitinib cream.Patients initially randomized t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ff69cb1367d0a0c21105774127edbf4
https://pubmed.ncbi.nlm.nih.gov/36574595
https://pubmed.ncbi.nlm.nih.gov/36574595
Autor:
Andrew Blauvelt, Richard Langley, Eric Simpson, Richard B. Warren, Antonio Costanzo, Hidehisa Saeki, Darryl Toth, Marie Tauber, Andreas Pinter, Mahreen Ameen, Kristian Reich
Publikováno v:
Journal of the American Academy of Dermatology. 87:AB181
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2186a4534b50398da504ac2a19936764
https://doi.org/10.1016/j.jaad.2022.06.754
https://doi.org/10.1016/j.jaad.2022.06.754
Autor:
Lawrence Eichenfeld, Eric Simpson, Kim Papp, Jacek Szepietowski, Leon Kircik, Darryl Toth, Seth Forman, Michael Kuligowski, May Venturanza, Haobo Ren, Amy Paller
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 6:s28
N/A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d0dff7d919a19c0c0decf40829986e1
https://doi.org/10.25251/skin.6.supp.28
https://doi.org/10.25251/skin.6.supp.28
Autor:
Kang Sun, May E. Venturanza, Eric L. Simpson, Darryl Toth, Donald Y.M. Leung, Seth Forman, Kim A. Papp, Jacek C Szepietowski, Lawrence F. Eichenfield, Michael E. Kuligowski, Leon H Kircik
Publikováno v:
Journal of the American Academy of Dermatology. 85(4)
Ruxolitinib (RUX) cream demonstrated potent anti-inflammatory and antipruritic efficacy in a phase 2 study in adults with atopic dermatitis (AD).To evaluate 8-week efficacy and safety in 2 phase 3 studies of RUX cream in patients with AD.Topical Ruxo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::859983a6040a437db0a1b7c897edc70d
https://pubmed.ncbi.nlm.nih.gov/34153395
https://pubmed.ncbi.nlm.nih.gov/34153395
Autor:
Darryl Toth, Stefan Beissert, Jean-Luc Perrot, Pedro Herranz, Vivian Laquer, Andrew Blauvelt, Ketty Peris, Andreas Wollenberg, Andrew Pink, Hidehisa Saeki, Stine Fangel
Publikováno v:
Annales de Dermatologie et de Vénéréologie - FMC. 1:A357
Introduction Des options therapeutiques a long terme sont necessaires pour les patients atteints de dermatite atopique (DA) moderee a severe. Le tralokinumab est un anticorps monoclonal entierement humain qui cible specifiquement l’interleukine-13,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17527bf2690432d8d3749f32fcc4c88f
https://doi.org/10.1016/j.fander.2021.09.432
https://doi.org/10.1016/j.fander.2021.09.432
Autor:
Andrew Pink, Darryl Toth, Pedro Herranz, Andrew Blauvelt, Andreas Wollenberg, Vivian Laquer, Hidehisa Saeki, Jean-Philippe Lacour, Stefan Beissert, Stine Fangel, Ketty Peris
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 5:s59
N/A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1489d8c0dea051b87db7764b9a655338
https://doi.org/10.25251/skin.5.supp.59
https://doi.org/10.25251/skin.5.supp.59
Autor:
Matthew Zirwas, Zoe Draelos, Janet Dubois, Leon Kircik, Angela Moore, Linda Stein Gold, Javier Alonso-Llamazares, Michael Bukhalo, Suzanne Bruce, Kimmie Eads, Lawrence Green, Scott Guenthner, Laura Ferris, Seth Forman, Steven Kempers, Edward Lain, Charles Lynde, David Pariser, Darryl Toth, Paul Yamauchi, Patrick Burnett, David Berk
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 5:s94
N/A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2cbf438dd510d352bba94ca28d6b15c6
https://doi.org/10.25251/skin.5.supp.94
https://doi.org/10.25251/skin.5.supp.94
Autor:
Kim Papp, Darryl Toth, Kang Sun, May E. Venturanza, Eric L. Simpson, Lawrence Eichenfeld, Jacek C Szepietowski, Leon H Kircik, Seth Forman, Michael E. Kuligowski
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 5:s63
N/A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7cc27700eac95989beacb18746bfa046
https://doi.org/10.25251/skin.5.supp.63
https://doi.org/10.25251/skin.5.supp.63